Featured Findings:

• Bacteria, protozoa and nematodes, oh my!: seeking new drugs against COVID-19 
  • Why might drugs that kill malaria parasites or bacteria also kill coronaviruses? Evolutionarily, these pathogens could hardly be more different, yet some of these drugs are gaining traction in the search for a drug effective against COVID-19, as scientists and clinicians test a variety of old and new drugs. Read more

• 11 Steps to a Successful CRISPR Knock-In
  • Knock-ins are hard, for a long time people even said hey were impossible, but we are nearing an 80% success rate for CRISPR knock-ins in zebrafish so we want to share with you what we believe to be the 11 steps necessary to have a successful knock-in project. Read more

• Seventeen Minutes of Science: Spreading out from Kendall (Episode 6)
  • Even before COVID-19, lab space in the coveted Boston-area was expensive, which resulted in crowding into smaller square footage where coworkers were working in close quarters to keep costs manageable. With social distancing measures in place now and for the foreseeable future, what does this mean for labs? Check out the full interview where Ben Jussila discusses this subject with Gary Kaufman, the COO and co-founder of ABI-LAB. Watch the interview

• COVID-19 provided UO disease course a teaching moment 
  • Our Chief Global Health Officer and one of our co-founders, Dr. Janis Weeks, has been teaching a course on tropical diseases at the University of Oregon for many years. A portion of her class has always focused on emerging infectious diseases, and this year as the novel coronavirus started to spread during winter term, her class had a real-time example in play. Read more

• Breakthrough could help develop therapies for childhood brain disorder
  • A new breakthrough out of the University of Sheffield using zebrafish could pave the way for therapies to treat rare childhood brain disorders by helping us to understand how they develop. Learn more